Skeletal muscle development occurs asynchronously and it has been proposed to be dependent upon the generation of temporally distinct populations of myogenic cells. This long-held hypothesis has not been tested directly due to the inability to isolate and analyze purified populations of myoblasts derived from specific stages of prenatal development. Using a mouse strain with the GFP reporter gene targeted into the Myf5 locus, a cell-sorting method was developed for isolating embryonic and fetal myoblasts. The two types of myoblasts show an intrinsic difference in fusion ability, proliferation, differentiation and response to TGFβ, TPA and BMP-4 in vitro. Microarray and quantitative PCR were used to identify differentially expressed genes both before and after differentiation, thus allowing a precise phenotypic analysis of the two populations. Embryonic and fetal myoblasts differ in the expression of a number of transcription factors and surface molecules, which may control different developmental programs. For example, only embryonic myoblasts express a Hox code along the antero-posterior axis, indicating that they possess direct positional information. Taken together, the data presented here demonstrate that embryonic and fetal myoblasts represent intrinsically different myogenic lineages and provide important information for the understanding of the molecular mechanisms governing skeletal muscle development.
Introduction
All the skeletal muscles in vertebrate body (with the exception of some craniofacial muscles) derive from progenitors present in the somites (Gossler and Hrabe-DeAngelis, 1998) , transient mesodermal units, which form in a cranio-caudal succession by segmentation of the paraxial mesoderm. Each newly formed somite rapidly differentiates into a ventral scle-rotome and a dorsal dermomyotome from which myogenic precursors originate. Skeletal muscle is formed in successive distinct, though overlapping steps involving different myoblast populations (Tajbakhsh, 2005) . The first multinucleated muscle fibers that appear in the embryo are called primary fibers, and are formed by embryonic myoblasts which differentiate by fusing with each other. This phase, which is usually referred to as primary myogenesis takes place at approximately E10.5-12.5 in the mouse. Only a fraction of myogenic progenitors terminally differentiate during primary myogenesis. The remaining are kept in a committed (likely depending upon Pax3/Pax7 expression (Kassar-Duchossoy et al., 2005; Relaix et al., 2005) ), but undifferentiated state until a new wave of myogenesis takes place between E14.5 and E17.5. This latter phase is called secondary myogenesis and depends upon fusion of fetal myoblasts to give rise to secondary fibers (originally smaller and surrounding primary fibers (Kelly and Zacks, 1969) ). Fetal myoblasts have also been proposed to fuse in part with primary fibers (Zhang and McLennan, 1995) . From E16.5, satellite cells can be morphologically identified as mononucleated cells lying between the basal lamina and the fiber plasma membrane (Mauro, 1961) . They are responsible for postnatal growth and repair of skeletal muscle.
Work from a number of laboratories, including our own, identified specific features of embryonic and fetal myoblasts, and satellite cells, that characterize them as distinct classes of myogenic cells (Cossu and Biressi, 2005; Cossu and Molinaro, 1987; Miller et al., 1999) . Embryonic and fetal myoblasts, thought to generate primary and secondary fibers respectively, differ in the morphology of the myotubes they generate in vitro, and in the myosin heavy chains isoforms and muscle enzymes that they express (Barbieri et al., 1990; Bonner and Hauschka, 1974; Ferrari et al., 1997; Pin and Merrifield, 1993; Zappelli et al., 1996) . They also differ with respect to media requirements (White et al., 1975) , integrin-extracellular matrix interactions (Blanco-Bose and , resistance to inhibitors of myogenesis such as phorbol esters (Cossu et al., 1988) and TGFβ (Cusella-DeAngelis et al., 1994) . Previous studies have been limited by the heterogeneity of the populations analyzed, since no markers or methods were available to isolate pure populations of murine embryonic and fetal myoblasts. As myoblasts represent only a minority of the cells that comprise the embryonic and fetal mesoderm, it was always possible that any differences observed in vitro may simply be due to differences in the signals from neighboring cells. Even the reported asynchrony of fusion into primary and secondary fibers could simply be the consequence of a stochastic process. Thus, the first cells to differentiate within an asynchronous population fuse into myotubes that then secrete growth factors such as bFGF. bFGF could cause a second wave of proliferation in those myoblasts, which, by chance, had not yet become post-mitotic. Moreover, the inability to isolate and work with pure population of embryonic and fetal myoblasts has so far prevented any detailed phenotypic analysis.
In this study, a cell-sorting method for isolating embryonic and fetal myoblasts was developed using a mouse strain with the GFP gene targeted into one allele of the Myf-5 locus (Kassar-Duchossoy et al., 2004) , allowing fluorescence activated cell sorting (FACS) of embryonic and fetal myoblast populations. We now show that highly purified embryonic and fetal myoblasts differ in proliferation, differentiation, fusion ability and sensitivity to inhibitors of myogenesis (TGFβ, TPA, BMP-4) in vitro. The molecular mechanisms responsible for this myoblast diversification were explored by using microarray analysis and/ or real-time PCR on purified populations of myoblasts. This approach revealed a number of genes that are differentially expressed both before and after differentiation, in the two populations. These include several genes which are known to be involved in skeletal muscle development and physiology such as Pax3, Paraxis, Muscle Creatin Kinase, Integrin α-7 and PkCθ. Interestingly, a Hox code is expressed along the antero-posterior axis specifically in embryonic but not in fetal myoblasts. Moreover, embryonic and fetal myotubes selectively express genes characteristic of adult slow and fast contracting fibers, respectively. Together, these results demonstrate that embryonic and fetal myoblasts represent intrinsically different myogenic lineages and open the possibility to explore the molecular mechanisms responsible for myoblast diversification.
Materials and methods

Cell isolation
Myf5 GFP-P mice were produced by targeting the gene encoding enhanced Green Fluorescent Protein (GFP) into the Myf5 locus (Kassar-Duchossoy et al., 2004) . Where indicated, heterozygous Myf5 GFP-P/+ mice were crossed with wild-type (wt) mice or homozygous Tg:3F-nlacZ-2E transgenic mice that express a transgene encoding nuclear-localizing β-galactosidase under the transcriptional control of the myosin light chain 1/3-fast promoter, expression which is restricted to terminally differentiated skeletal and cardiac muscle (Kelly et al., 1995) .
Embryonic myoblasts were isolated from E11.5 (or E10.5 for purification from different axial levels) embryos; fetal myoblasts from E16.5 Myf5 GFP-P/+ mice. Myf5 GFP-P/+ embryos and fetuses were distinguished from their wild-type littermates by examination under a fluorescence microscope. Embryonic myoblasts were obtained from the somites and limbs of E11.5 embryos; fetal myoblasts from E16.5 fetuses after removal of the head, internal organs and skin to enrich for myoblasts in the dissociated cell preparation. Tissues were dissociated with 0.15 mg/ml collagenase Type V (Sigma), 0.4 mg/ml dispase (Gibco), 0.1 mg/ml Dnase I (Roche) in a buffered solution (Hank's Balanced Salt Solution (HBSS; BioWhittaker) supplemented with 15 mM HEPES, 15 mM glucose, 1.5 mM MgSO 4 , 0.3% (W/V) bovine serum albumin (BSA), pH 7.4). When embryonic myoblasts were isolated from different axial levels of E10.5 embryos, the limb buds were removed to avoid contamination with limb myoblasts.
Dissociated cells were resuspended in DMEM-high glucose (Gibco), supplemented with 20% fetal calf serum (FCS; BioWhittaker), 20 mM HEPES and 2 mM EDTA and filtered through 40-μm cell strainers (Falcon) before sorting using a Vantage Sorter SE (Becton-Dickinson) at a flow rate of 3000 cells per second. GFP was exited at 488 nm using an argon laser. Specific green fluorescence, forward (FSC) and side (SSC) light scatter were measured. FSC and SSC parameters were used to gate out cell clumps and debris. Cells dissociated from wild-type littermates were used to set the gating to exclude green autofluorescence. The purity of each sorted sample was evaluated by immediate reanalyzing of approximately 10,000 cells.
The cell cycle progression of the GFP-positive and GFP-negative cells was analyzed by FACS after Hoechst staining. Cells were incubated for 90 min at 37°C in 5 μg/ml Hoechst 33342 (Sigma), pelleted and maintained at 4°C before FACS analysis. PE-conjugated anti-mouse CD45 antibodies or mouse IgG1, k immunoglobulins (isotypic control) (Pharmingen) were used to evaluate the presence of CD45 in the GFP-positive cells.
All experiments were performed under internal regulations for animal care and handlings.
Cell culture
For the differentiation assay, sorted embryonic and fetal myoblasts were resuspended in DMEM-high glucose supplemented with 20% horse serum (BioWhittaker) and 20 mM HEPES and spotted onto calf skin collagen (Sigma)coated dishes, at a density of approximately 80,000 cells/cm 2 . Where indicated, TGFβ-1 (10 ng/ml; Sigma), human recombinant BMP-4 (50 ng/ml; RD), TPA (1 μM; Calbiochem) and L-685,458 (1 μM; Sigma) were added to the media 4 h after plating and re-added every 24 h. Each day, half of the medium was replaced with fresh medium.
To test colony forming capacity, sorted cell suspensions from wild-type E11.5 and E16.5 mice were plated at clonal density (approximately 200 cells/ cm 2 ) and cultured in DMEM-high glucose supplemented with 20% horse serum (BioWhittaker), 20 mM HEPES and 3% chicken embryo extract for 3 days. The myogenic properties of the colonies were verified by staining with anti-MyoD and anti-desmin antibodies.
To evaluate the response to regulatory molecules, C2C12 (ATCC) myoblasts were plated at 20,000 cells/cm 2 in DMEM-high glucose supplemented with 10% fetal calf serum. One and two days after plating, the medium was replaced with DMEM-high glucose supplemented with 2% fetal calf serum (FCS) to induce differentiation. TGFβ-1, TPA and BMP-4 were added to the medium the day after plating and re-added every 24 h, as previously described for embryonic and fetal myoblasts.
Immunofluorescence/β-Galactosidase staining
Cell cultures were fixed in 4% paraformaldehyde for 10 min at 4°C. For βgalactosidase staining cells were incubated at 37°C for 5 h in X-Gal buffer (1 mg/ml 5-bromo-4-chloro-3-indolyl-β-D-galactosidase, 5 mM K 4 Fe(CN) 6 , 5 mM K 3 Fe(CN) 6 , 2 mM MgCl 2 in PBS). For BrdU incorporation assays, cells were incubated with 50 μm BrdU (Sigma) in complete medium for 1 h, washed, fixed in a 95% ethanol/5% (V/V) acetic acid solution for 20 min and then treated with 1.5 M HCl for 10 min at room temperature. Immunofluorescent staining was carried out using the following antibodies: rabbit anti-all sarcomeric myosin heavy chains (MyHCs) (Minasi et al., 2002) ; rabbit anti-GFP (Molecular Probes); rabbit anti-desmin (Sigma); mouse anti-MyoD (clone 5.8A, DakoCytomation); mouse anti-BrdU (Amersham); mouse anti-myogenin (F5D, kindly provided by Dr. W.E. Wright). Preparations were blocked with 10% donkey serum at room temperature for 30 min and then incubated at 4°C overnight with primary antibodies in PBS containing 1% BSA and 0.2% Triton. Preparations were then washed with PBS and incubated for 1 h at room temperature with Alexa Fluor 594-conjugated, donkey anti-rabbit IgG or Alexa Fluor 488conjugated, donkey anti-mouse antibodies (Molecular Probes). Finally, preparations were washed and mounted in Vectashield mounting medium containing DAPI (Vector Lab Inc.). In some experiments Hoechst was used to stain the nuclei instead of DAPI.
The number of cells containing LacZ expressing nuclei, GFP, MyHCs-, myogenin-or desmin-positive cells and total nuclei were counted in at least 3 microscopic fields at 10× magnification and 6 microscopic fields at 20× magnification for each replicate. Data were obtained from 2-4 independent experiments run in duplicate. To determine the colony forming ability, the number of MyoD + and desmin + cells in each myogenic clone was quantified. At least 50 myogenic clones were counted in each experiment. Data were obtained from 3 separate experiments. Data were analyzed using unpaired Student's t-tests.
Microarray analysis
Purified embryonic and fetal myoblasts were stored at − 80°C and pooled together for total RNA extraction. Total cellular RNA was isolated from cell populations using RNeasy RNA isolation kit (Qiagen) following manufacturer's recommendations. Disposable RNA chips (Agilent RNA 6000 Nano LabChip kit) were used to determine the concentration and purity/integrity of RNA samples using Agilent 2100 bioanalyzer. C2C12 myoblasts were grown in DMEM-high glucose supplemented with 10% fetal calf serum and processed for RNA extraction in the same way. For each population, 5 μg of total RNA was used for cDNA synthesis. cDNA synthesis, biotin-labeled target synthesis, MOE430A and B GeneChip (Affymetrix) arrays hybridization, staining and scanning were performed according to the standard protocol supplied by Affymetrix. The amount of a transcript mRNA (signal) was determined by the Affymetrix Microarray Suite software (MAS 5.0) absolute analysis algorithm as already described (Liu et al., 2002) . All expression values for the genes in the MAS 5.0 absolute analyses were determined using the global scaling option. Pair-wise analyses between samples were performed using MAS 5.0 comparison analysis algorithm. Microarray experiments have been submitted to GEO in a MIAME compliant format (Minimum Information About a Microarray Experiment) (Brazma et al., 2001) . The accession numbers are GSM124899, GSM124900, GSM124901, GSM124902, GSM124903 and GSM124904.
Microarray data, along with the MIAME checklists have been submitted as Supplementary material.
The processed data were further examined using Microsoft Excel. Low values were arbitrarily reassigned threshold values of 50 for purposes of calculating fold changes. Subsequently, probe sets with fold change of greater than 3 and with Gene Ontology biological and/or molecular function and/or cellular localization term were used to compare embryonic data (baseline) against fetal myoblasts and C2C12. Excel files with numeric expression values, qualitative absent (A)/marginal (M)/present (P) call values and relative fold induction accompanies the manuscript (Supplementary Tables 5 and 6). These genes were hierarchically clustered using the gplots library of the R software (http://www.R-project.org). Hierarchical clustering of both genes and samples was performed using Pearson correlation as similarity measure (Fig. 6B ).
Using the Affymetrix software GObrowser (http://www.affymetrix.com), the numbers of probe sets on Mouse Expression Array 430 A and B GeneChip corresponding to the Gene Ontology (GO) terms 'Transcription' (GOID: 6350), 'Cell adhesion molecules' (GOID: 7155), 'Pattern specification' (GOID: 7389), 'Embryonic development' (GOID: 9790) and 'Signal transduction' (GOID: 7165) were calculated as of the November 2005 annotation build. Percentiles for each GO term category were calculated by dividing the numbers in each category by the total number of probe sets with an annotated GO biological function ( Fig. 6C ).
Quantitative real-time polymerase chain reaction
RNA was extracted and quantified as described above. cDNAs were reverse transcribed from total RNA samples (100 ng per sample) using High Capacity cDNA Archive Kit (Applied Biosystems) as described in the manufacturer's protocol. TaqMan PCR reactions were carried out from cDNA samples using custom TaqMan low density arrays (Applied Biosystems) by means of ABI PRISM 7900 HT Sequence Detection Systems. Gene expression profiling was achieved using the Comparative CT method of relative quantification.
Results
Purification of embryonic and fetal myoblasts from Myf5 GFP-P/+ mice To obtain pure populations of embryonic and fetal myoblasts, GFP-expressing cells were isolated by FACS from cellular suspensions obtained from Myf5 GFP-P/+ mice at E11.5 and E16.5, respectively (Cossu et al., 1988) . Myf5 is the first of the myogenic regulatory factors to be expressed in proliferating myoblasts and its regulatory sequences drive the expression of the reporter gene in cells entering the myogenic lineage (Tajbakhsh et al., 1996) . Since this study aimed to investigate phenotypically normal embryonic and fetal myoblasts, cells were isolated from heterozygous mice in which the presence of a single functional Myf5 allele is sufficient to drive normal myogenesis (Tajbakhsh et al., 1996) . Approximately 1-2% of the cells obtained from the mesoderm digest of both E11.5 and E16.5 mice expressed GFP (Figs. 1A, C). It was therefore possible to sort 10,000-15,000 cells from each E11.5 embryo and 3-4 times as many cells from each E16.5 fetus. Both sorted populations presented an overall purity of more than 95% (respectively 95.8 ± 1.9 and 95.5 ± 2.1 for E11.5 and E16.5) when reanalyzed by FACS immediately after sorting (Figs. 1B, D; Supplementary Table 3 ) and greater than 98% (respectively 98.9 ± 1.8 and 98.1 ± 1.0 for E11.5 and E16.5) when assayed with anti-GFP antibodies after 8 h of culture (Supplementary Figs. 11A-D). To demonstrate that cells sorted from Myf5 GFP-P/+ mice were indeed myogenic, immunofluorescent staining with antibodies specific for the myogenic marker desmin was performed on both purified embryonic and fetal cell populations The cell cycle status of the GFP-positive myoblasts was analyzed by FACS after Hoechst staining and was compared with that one of the corresponding GFP-negative fractions, consisting mainly of fibroblasts (Figs. 1I, L). For both embryonic and fetal populations, a large proportion (33 and 32% respectively) of the GFP-expressing cells compared with the GFP-negative cells, was in the S + G2 + M phases of the cell cycle, suggesting that both types of myoblasts were proliferating at the moment of isolation.
Phenotypic characterization of purified embryonic and fetal myoblast cultures
Previous studies identified several phenotypic differences between embryonic and fetal myoblasts. However, because heterogeneous populations were studied, these differences could result from signals coming from the surrounding cells rather than intrinsic proprieties of the two populations of myoblasts. To investigate in vitro differentiation, pure populations of embryonic and fetal myoblasts were obtained from Myf5 GFP-P/+ //Tg:3F-nlacZ-2E mice (see Materials and methods) as in these mice, β-galactosidase expression is under the control of myosin light chain 3F regulatory sequences and thus restricted to differentiated, striated muscle cells. When cultured under conditions that promote differentiation, purified embryo-nic and fetal myoblasts generated differentiated cells with dramatically different morphologies. After 3 days in vitro, embryonic cultures contained mononucleated differentiated myocytes, usually aligned with each other (∼ 28% of total differentiated cells) and multinucleated myotubes containing only a few nuclei (< 20) (Figs. 2A and E) . At later times, embryonic cultures contained large, morphologically abnormal multinucleated cellular structures, which rapidly collapsed and detached from the dish (Fig. 2B ). In contrast, after 3 days, fetal cultures contained larger myotubes than the embryonic cultures with significantly more nuclei in large clusters in the center of the myotubes (21.6% of total differentiated nuclei were in myotubes with ≥ 20 nuclei) (Figs. 2C and E). After 6 days in culture, the fetal myotubes were larger with greater numbers of ramifications ( Fig. 2D ; data not shown). Moreover spontaneously contracting fetal myotubes were common, whereas contracting embryonic myotubes were almost never observed, suggesting that the molecular mechanisms regulating the excitation, contraction or adhesion should be different in the two populations.
To determine if murine embryonic and fetal myoblasts could fuse to each other, pure populations of embryonic and fetal myoblasts were obtained respectively from Myf5 GFP-P/+ // Tg:3F-nlacZ-2E and Myf5 GFP-P mice, mixed in 1:1 proportion and cultured for 3 days in vitro. The presence of MyHCs + myotubes containing both β-galactosidase-positive and -negative nuclei indicated that the two classes of myoblasts can fuse with each other ( Supplementary Figs. 12A, A′) . Nevertheless, when the number of myotubes containing both βgalactosidase-positive and -negative nuclei (heterotypic myotubes) was counted and compared with the number of myotubes containing exclusively β-galactosidase-positive or -negative (A, C) GFP-expressing cells are separated in two-dimensional dot plot of GFP (abscissa) and intrinsic SSC (ordinate). Forward scatter and side scatter were previously used to gate out cell clumps and debris from the total initial population and green autofluorescence was evaluated on preparations obtained from wild-type mice at the same stage (not shown). (C, D) An immediate reanalysis of the sorted populations by FACS confirmed the high degree of purity obtained (>95% of cells are GFP + ). Almost all the cells sorted from Myf5 GFP-P/+ embryos (G) and fetuses (H) express myogenic markers, as assayed by immunofluorescence with anti-desmin antibodies after 3 days of culture. In contrast, unsorted embryonic (E) and fetal (F) populations contain only a small fraction of myoblasts. Dapi was used to stain nuclei. Scale bar,100 μm. (I, L) The cell cycle progression of the GFP-positive cells (myoblasts; green) was analyzed by FACS after Hoechst staining and was compared with the corresponding GFP negative fraction (red). For both embryonic (I) and fetal population (L), GFP-expressing cells present an enhanced number of cells in replicative phases (S + G2 + M phase). nuclei (omotypic myotubes), these latter appeared more frequently than expected for a stochastic process (Supplementary Figs. 12A, A′ and B). These observations suggest that under our experimental conditions embryonic and fetal myoblast, although able to fuse to each other, are predisposed to fuse with myoblasts of the same type with higher affinity.
When embryonic and fetal myoblasts were plated at clonal density under conditions that promote proliferation (see Materials and methods), the average number of cells per clone differed dramatically between the two preparations. Embryonic myoblasts generated smaller colonies (2.5 ± 1.0 vs. 10.3 ± 3.1 MyoD + and 2.9 ± 1.3 vs. 11.4 ± 4.6 desmin + cells/myogenic colony from embryonic and fetal populations, respectively), demonstrating that the two populations have different clono-genic potency in vitro ( Fig. 3) . To determine the percentage of cells in the S phase of the cell cycle in the two populations, embryonic and fetal myoblasts purified from the Myf5 GFP-P/+ mice were pulsed with BrdU 1 day after plating. A larger proportion (44.7 ± 3.1%) of fetal myoblasts incorporated BrdU in comparison with the embryonic population (37.3 ± 3%), even though the difference was far less dramatic than that observed in the clonal analysis ( Fig. 3F ). To examine whether the different proliferation potency correlates with the timing of differentiation in vitro, embryonic and fetal myoblasts were maintained in culture for 8 h and then stained for the expression of the differentiation markers, myogenin and sarcomeric myosin heavy chains (MyHCs). A greater percentage of embryonic myoblasts expressed myogenin (38.9 ± 3.6%) and myosin (33.8 ± 6.2%) in comparison with the fetal population (27.3 ± 1.3% and 17.5 ± 3.7% for myogenin and myosin, respectively) ( Fig. 4) , indicating that the reduced proliferation observed in populations of embryonic myoblasts in vitro is associated with an increased tendency towards differentiation. Note that embryonic myoblasts differentiate into mononucleated myocytes or myotubes with few nuclei whereas fetal myotubes are longer and contain numerous nuclei. After 6 days, branched myotubes were observed only in the fetal population, whereas the embryonic population forms enlarged cellular structures, which rapidly collapse detaching from the Petri dish (asterisk). Scale bar, 50 μm. (E) The fusion ability was quantified by counting the number of terminally differentiated nuclei contained in myotubes of different size (1-5, 5-10, 11-20 and >20 nuclei). After 3 and 6 days fetal myotubes contain more nuclei than embryonic myotubes. Bars represent ± standard deviation (SD). *p < 0.05 vs. embryonic.
It has been reported that TGFβ and the phorbol ester TPA (Cossu et al., 1988; Cusella-DeAngelis et al., 1994) inhibit fetal, but not embryonic myoblast differentiation. Those studies were carried out using unpurified myoblast preparations. To test whether TGFβ-1 and TPA act directly on embryonic and fetal myoblasts, purified populations of embryonic, fetal and C2C12 myoblasts were treated with TGFβ-1, TPA or BMP-4 (which has been reported to inhibit differentiation of satellite cells and C2C12 myoblasts ). The degree of differentiation in treated and control cultures was evaluated by counting the percentage of nuclei contained in terminally differentiated (i.e., sarcomeric MyHC-positive) cells. Fetal myoblasts (Figs. 5B, B′, B″, B‴) and C2C12 (Figs. 5C, C′, C″, C‴) were significantly more sensitive to all the factors tested in comparison with embryonic myoblasts (Fig. 5A , A′, A″, A‴). However, whereas embryonic myoblast differentiation was completely unaffected by TGFβ-1 ( Fig. 5D′ ), TPA ( Fig.  5D″ ) and BMP-4 ( Fig. 5D‴ ) had a modest but detectable effect. Thus while fetal myoblasts and C2C12 myoblasts show similar responses to TGFβ-1, TPA and BMP-4, both populations are intrinsically different from embryonic myoblasts in their responses to these factors. It is worth noting that, also after 3 days in vitro in absence of any treatment the percentage of terminally differentiated cells is higher in embryonic cultures ( Fig. 5D ), further confirming the accelerated differentiation of embryonic myoblasts.
Gene expression profiling of undifferentiated embryonic, fetal and C2C12 myoblasts
A genome-wide analysis of gene expression in embryonic and fetal myoblasts was carried out using cRNA from freshly sorted, uncultured, GFP + cells (for a precise quantification of the purity see Supplementary Table 3 ), hybridized on Affymetrix Mouse Expression Array 430 A and B GeneChip set. This approach allowed the evaluation of the levels of expression of more than 39,000 transcripts following hybridization with approximately 45,000 probe sets. RNA was isolated from embryonic and fetal myoblasts purified from more than 150 E11.5 embryos and more than 50 E16.5 fetuses, respectively. The high number of embryos and fetuses used should compensate for individual variability.
The transcriptomes of embryonic and fetal myoblasts revealed many differences ( Fig. 6A ) and genes with a consistent differential gene expression of more than 3-fold (fetal vs. embryonic log2 ratio <−1.58 or > 1.58) and an annotated biological/molecular function or cellular localization (Gene Ontology) were selected for further investigation. This differential limited the set of candidates to 337 (275 with GO annotated biological function) transcripts found to be more highly expressed in embryonic myoblasts ( Supplementary  Table 5 ) and to 237 (180 with annotated biological function) in fetal myoblasts ( Supplementary Table 6 ). TaqMan PCR was used to validate differential expression of more than 40 genes. The analysis was performed on material independently collected from that used for the microarray ( Supplementary  Table 3 ), ensuring a reliable biological replicate. The results, although sometimes with different magnitude, reflected the GeneChip data (Table 1, Supplementary Tables 5-6 and not  shown) .
A gene expression profile of C2C12 myoblasts was also performed. Not surprisingly, the entire transcriptome of the cell line C2C12 is significantly different form that of embryonic and fetal myoblasts, which both are primary cells and thus appeared relatively more similar to each other (not shown). Nevertheless, when only the 574 transcripts that were differentially expressed in embryonic and fetal myoblast populations were considered, a similarity appeared in their profile of expression between C2C12 and fetal myoblasts (Fig. 6B ). Interestingly C2C12 share many features with fetal myoblasts, including responses to TGFβ, TPA and BMP-4 (see above), consistent with a correlation between genetic program and behavior in vitro.
Classification of the genes upregulated in embryonic myoblasts by GO terms revealed that transcription factors, as well as genes implicated in embryonic development and pattern specification, were highly represented compared with all genes represented on the Mouse Expression Array 430. Conversely, cell adhesion molecules were relatively highly represented among the genes identified in fetal myoblasts. Finally a significant number (∼ 20%) of differentially expressed genes are involved in signal transduction (Fig. 6C) .
In particular, the microarray analysis showed that several genes involved in the TGFβ and BMP-4 signaling pathways were relatively highly expressed in fetal myoblasts, such as the proteoglycans Fibromodulin, Decorin and Biglycan, Latent transforming growth factor-β binding proteins 3 and 4, Cited1 and TGFβ receptor II. Interestingly some of them (i.e., Decorin, Biglycan, Ltbp3 and Tgfβ receptor II) were also relatively highly expressed in the TGFβ and BMP-4 responsive C2C12 myoblasts ( Supplementary Table 6 ). Moreover, the inhibitory Smad6 and Smad7 which have an inhibitory effect on TGFβ superfamily signaling (Imamura et al., 1997; Nakao et al., 1997) , were more highly expressed in embryonic myoblasts (respectively 4.6 and 1.7 times; Table 1 and Supplementary microarray data). These data provide important information for the understanding of the molecular mechanisms governing the different sensitivity to TGFβ and BMP-4 shown by embryonic and fetal myoblasts. It has been previously reported that PkCθ is more highly expressed during secondary myogenesis and when overexpressed into embryonic myoblasts, is able to induce a certain degree of sensitivity to TGFβ (Zappelli et al., 1996) . The microarray analysis revealed a high intensity of the hybridization signal for PkCθ exclusively in the fetal population, but the statistical algorithm used to elaborate the data indicated a possible absence of PkCθ in both embryonic and fetal myoblasts ( Supplementary Table 6 ). In order to clarify this discrepancy real-time PCR was performed, which showed an enhanced expression (13.3-fold) of PkCθ in fetal compared with embryonic myoblasts (Fig. 7E) . The microarray analysis also revealed that several members of the Notch signaling pathway, including Notch1, Jagged1 and Deltex4 were significantly more highly expressed in fetal myoblasts (Table 1). In contrast, members of the FGF family (Fgf-4, 5, 6 and 9) were relatively high in embryonic myoblasts. The reported roles of FGFs in controlling muscle differentiation (Olson, 1992) and migration of embryonic myoblasts into the limb suggest an action through autocrine/paracrine mechanisms (Fox and Swain, 1993) . It has also been reported that PDGF is able to enhance the migration of the embryonic myoblasts to the limb . The relatively higher expression of both α and β PDGF receptors in embryonic myoblasts detected by GeneChip analysis suggests that fetal myoblasts could be less responsive to PDGF. Interestingly, reduced PDGF binding by fetal myoblasts compared with satellite cells has previously been reported in the chick (Yablonka-Reuveni and Seifert, 1993), although embryonic myoblasts were not included in that study. This and the observations reported here, suggest that the different myogenic populations differ in their ability to bind PDGF.
Many cell adhesion molecules, such as integrin-α7, -α8, -α4 and -α9, laminin-β2, -β4, -β and -β1, dystroglycan, Mcam, CD44, CD34, Vcam-1 and Semaphorin 3d and 4g are differentially expressed between embryonic and fetal myoblasts (see Table 1 ), offering a possible explanation for both the different fusion ability and the preferential generation of omotypic myotubes shown by the two population of myoblasts. In particular the enhanced expression of Vcam-1 in fetal myoblasts is consistent with a previous report, which proposed that Vla-4/Vcam-1 interactions influence alignment of secondary myoblasts along primary myotubes and/or the fusion of secondary myoblasts (Rosen et al., 1992) . Conversely the relatively high expression of several different laminins by fetal myoblasts is consistent with the appearance of a basal lamina at the beginning of secondary myogenesis (Kelly and Zacks, 1969) . The expression of Integrin-α7 was further evaluated by real-time PCR on purified embryonic and fetal population both before and after differentiation in vitro (Fig. 7F) . The level of expression resulted 16.9-and 4.2-fold higher in fetal myoblasts before and after differentiation, respectively, while only traces were detected in the embryonic population before differentiation ( Supplementary Table 6 ). This differential expression of Integrin-α7, which has been previously proposed as marker of Fig. 6 . Gene expression profiling of embryonic, fetal myoblasts. (A) Log scatter plots, where the x-axis is the embryonic myoblasts and the y-axis is the fetal myoblasts signal. The diagonal lines represent the fold change thresholds. (B) Hierarchical clustering of genes expressed more than 3 times in embryonic or fetal myoblasts (see Materials and methods). The number of upregulated (shaded of red) and downregulated (shaded of blue). Different shades indicate the signal log ratios between the individual comparisons, and a color scale bar represents these values. Note that regarding these genes C2C12 is more similar to fetal myoblasts than to embryonic myoblasts as indicated by the tree structure on the top. (C) Enrichment of genes encoding for developmental regulatory factors (GOID: 9790; 6350; 7389) and cell adhesion molecules (GOID: 7155) in embryonic and fetal myoblasts, respectively. The left pie chart represents the percentage of genes with the indicated GO terms among all the 275 genes with an annotated biological function expressed more than 3 times in embryonic myoblasts. The central pie chart represents the percentage of genes with the indicated GO terms among all the 180 genes with an annotated biological function expressed more than 3 times in fetal myoblasts. The right pie chart represents the percentage of genes with the indicated GO terms among all the 20451 genes with an annotated biological function on the Affymetrix Mouse Expression Array 430. Note that more than 20% of the differentially expressed genes is involved in the signal transduction (GOID: 7165). , as they claimed a strong expression of Integrin-α7 protein in undifferentiated embryonic myoblasts.
Moreover microarrays indicate that many genes encoding components of the extracellular matrix were more highly expressed in fetal myoblasts, including several collagenous and non-collagenous proteins (Table 1) . Interestingly, the hematopoietic marker CD45 resulted absent in both embryonic and fetal myoblasts ( Supplementary Fig. 13 and Supplementary microarray data) indicating that they are not hematopoietic in origin.
A small number of transcription factors were more highly expressed in fetal compared with embryonic myoblasts, including all four members of NfI family (Funk and Wright, 1992) and the proliferation/differentiation regulators Fos-b and Jun-b (Li et al., 1992) (Table 1) . However, a greater number of transcription factors were more highly expressed in embryonic myoblasts. These include Pax3 which is known to control the delamination and migration of somitic muscle progenitors to the limb bud (Relaix et al., 2004) and is able to activate MyoD expression as does Myf5 in the embryonic body (Tajbakhsh et al., 1997) . Differential expression of Pax3 in embryonic and fetal populations, both before and after differentiation, was confirmed by quantitative real-time PCR (Fig. 7A) . Interestingly, several genes whose expression had previously been reported to be directly or indirectly linked to Pax3 expression, were also relatively higher in the embryonic population ( Table   Table 1 (continued) Genes more expressed in fetal myoblasts are depicted in grey. PCR data were reported in brackets for the genes whose differential expression was confirmed by real-time PCR. 1): i.e., Meox1, Paraxis (Fig. 7C) , Eya2 (2.5 times; Supplementary microarray data) (Ridgeway and Skerjanc, 2001) , and Caderin11 (Markus et al., 1999) . In addition, GeneChip analysis revealed also that Meox2 which has been shown to be an important regulator of limb myogenesis (Mankoo et al., 1999) and which is able to physically interact with Pax3 in vitro (Stamataki et al., 2001 ) was more highly expressed in embryonic myoblasts. Perhaps surprisingly, the expressions of the established Pax3 targets c-Met (Epstein et al., 1996) and Six-1 (Ridgeway and Skerjanc, 2001) were only slightly greater than in fetal myoblasts ( Fig. 7B and Supplementary microarray  data) , where Pax3 transcripts were almost undetectable, suggesting that their expression may also depend upon different regulators. Interestingly, fetal myoblasts show higher expression of the Pax3 paralogue Pax7 (2.7 times; Supplementary microarray data). Other genes such as Follistatin, MdfI, Ctgf, Id2, Twist and Mef2C that regulate muscle differentiation were found to be relatively highly expressed in embryonic myoblasts, as were several molecules which are known to be involved in skeletal muscle development or somitogenesis such as Ephrin B2, Uncx4.1, FoxC1 and FoxC2 and several Hox genes (Table  1 and Supplementary Table 5 ).
Functional Notch signaling is required for TGFβ, TPA and BMP-4 induced inhibition of fetal myoblasts differentiation
Fetal myoblasts differ to their embryonic counterparts for the different sensitivity to TGFβ, TPA and BMP-4 (see above). Interestingly, crosstalk between TGFβ superfamily and Notch signaling pathways has been recently reported for a few cellular types, including C2C12 and satellite cells Dahlqvist et al., 2003; Itoh et al., 2004) . As several members of the Notch pathway resulted strongly more expressed in fetal in comparison to embryonic myoblasts (see above), we decided to investigate the possible interplay between TGFβ, TPA, BMP-4 and Notch signaling in fetal myoblasts. With this aim we added to purified fetal myoblasts the γ-secretase inhibitor L-685,458, which hinders Notch intracellular domain release (Karlstrom et al., 2002) . After treatment with L-685,458 the differentiation block induced by TGFβ, TPA or BMP-4 was substantially reversed and the number of MyHC + cells increased respectively by 4.1-(from 11.6% to 44.1%), 2.3-(from 19.5% to 45.8%) and 2.5-fold (from 22.5% to 56.3%) compared with when TGFβ, TPA or BMP-4 were added with the control solvent (DMSO) (Figs. 8C-I) . The addition of L-685,458 in absence of TGFβ, TPA or BMP-4 also increased the percentage of MyHC + cells, although at minor extent (1.6-fold, from 32.0% to 50.3%) (Figs. 8A, B and I) . These observations strongly suggest that a functional Notch signaling is required for TGFβ, TPA and BMP-4 induced inhibition of fetal myoblasts differentiation.
Hox code is expressed in embryonic, but not in fetal myoblasts
Somite identity is specified by the combinatorial expression of Hox genes, usually referred to as the "Hox code" (Burke, 2000) . The microarray analysis revealed that almost all Hox genes are expressed in embryonic myoblasts, most of them at significantly higher levels than in fetal myoblasts (Supplementary Table 5 and Supplementary microarray data). To determine whether Hox genes potentially carry "positional information" in myoblasts, relative expression along the cranio-caudal gradient was investigated. Embryonic myoblasts were isolated from different axial levels of Myf5 GFP-P/+ embryos at the onset of primary myogenesis (E10.5). The head and limb buds were removed to avoid contamination with migratory myoblasts and the embryo was cut into three segments; an anterior portion containing the first 13-14 somites (from the neck to the posterior border of the forelimb); a central portion corresponding to the thoracic somites between the anterior and posterior limb buds; and a posterior portion extending caudally from the anterior border of the hind limb buds (Fig. 9A) . GFP-expressing myoblasts were sorted from each segment and the transcripts of 13 representative members of 12 different Hox paralogues were quantified by real-time PCR (Fig. 9B) . The pattern of expression obtained was comparable to that previously documented for the somites (Burke et al., 1995; Vogels et al., 1990) , consistent with the existence of a Hox code specifically in embryonic myoblasts.
Differential expression of muscle-structural genes in differentiated embryonic and fetal myotubes
Previous studies reported the differential expression of a small number of genes in embryonic and fetal myotubes (Barbieri et al., 1990; Ferrari et al., 1997; Zappelli et al., 1996) . Here, pure populations of embryonic and fetal myoblasts from Myf5 GFP-P/+ mice were induced to differentiate in vitro in the absence of other cell types and therefore in an environment free of external cellular influences. A gene expression profile was carried out on samples prepared after 3 days of differentiation in vitro. The expression of 81 genes, chosen for their known involvement in myogenesis and muscle function, was evaluated by quantitative, real-time PCR (Table 2 and Supplementary  Table 4 ). Thirteen genes were identified as being relatively highly expressed in fetal myotubes (> 2 times; fetal vs. embryonic log2 ratio >1), and 27 were identified in embryonic myotubes (> 2 times; embryonic vs. fetal log2 ratio < −1), consistent with different intrinsic genetic programs in the two populations after differentiation (Table 2) . Embryonic and fetal myotubes were found to differ in the expression of genes encoding a number of myofibrillar proteins, including MyHC-β, fast/neonatal MyHC, subunits of the troponin complex (slow/ cardiac troponin C, cardiac troponin I, slow troponin I, slow troponin T, fast troponin T), myosin light chain isoforms (MyLC1sa, MyLC1s/v, MyLC2s/v), tropomyosin isoforms (fast and slow α-tropomyosin), α-actinin2, and telethonin. Genes encoding the metabolic enzymes MCK (Ferrari et al., 1997) , β-Enolase (Barbieri et al., 1990) and lactate dehydrogenase 2 and Parvalbumin, Calsequestrin 1 and Serca1, involved in excitability and excitation-contraction coupling, were all relatively highly expressed in fetal myotubes. These observations are consistent with our previous observation that essentially only fetal myotubes spontaneously contract in vitro. In addition, differential expression was found for genes involved in cell adhesion, signal transduction and muscle differentiation, such as Integrin-α7, PkCθ, Berf-1, Foxo1, Nfatc4, follistatin, myostatin, Mrf4 and Eya2. Interestingly, some of these genes were also differentially expressed in undifferentiated myoblasts, i.e., follistatin, Eya2, telethonin, α-actinin2, Nfatc4, MCK, PkCθ and Integrin-α7 ( Figs. 7D-F) .
Among the 81 genes evaluated, 12 are known to be more highly expressed in adult slow contracting Type I fibers, and other 12 in fast contracting Type II fibers (Bottinelli and Reggiani, 2000) . Eleven of the 12 assayed genes known to be predominantly expressed in the slow fibers were more highly expressed in embryonic myotubes (for 8 of them, expression was more than 2-fold greater than in fetal myotubes). In contrast, 8 of the 12 genes characteristic of fast fibers were more highly expressed in myotubes derived from the fetal population (5 of them, more than 2-fold greater) (Fig. 10) . These observations suggest that each fiber type is, at least in part, determined by intrinsic programming of different myogenic precursor populations and that primary (embryonic) and secondary (fetal) fibers possess a genetic signature that can influence the eventual adult muscle fiber physiology.
Discussion
Isolation of pure populations of embryonic and fetal myoblasts Until now, it was possible to study embryonic and fetal myoblasts only in culture either in the presence of other cell types (mainly fibroblasts), or at clonal density under conditions that necessarily select for a clonogenic minor sub-population (DiMario and Stockdale, 1995) . Unlike avian myoblasts (Miller et al., 1999) , murine embryonic myoblasts (and to a lesser extent fetal myoblasts) form clones consisting of only a few cells that cannot be expanded further in vitro for biochemical and molecular analysis. In this study, a cell-sorting method for Fig. 9 . Embryonic myoblasts have a Hox code. (A) The expression level of 13 Hox genes belonging to different paralogue groups has been evaluated by real-time PCR on myoblasts isolated at different axial levels from E 10.5 Myf GFP-P/+ embryos: An → from neck until posterior part of the limb (somite 14); Ce → interlimb level; Po → from anterior part of the limb level until tail (fore and hind limb were dissected away). (B) The level of expression of each Hox gene is represented by the corresponding ΔCt value (ΔCt >25 is arbitrarily intended as absent). The Hox genes expression boundaries identified along the anterior-posterior axis in the isolated myoblasts from correlate with those documented in the somites (Burke et al., 1995; Vogels et al., 1990) . Abbreviations used: FL: forelimb; HL: hind limb; H: heart.
purifying committed, but undifferentiated murine embryonic and fetal myoblasts was developed using a knock-in mouse with the GFP gene targeted into the Myf5 locus (Kassar-Duchossoy et al., 2004). This has made it possible to isolate stage-specific, highly purified myogenic populations. Although FACS-based methods are available for the purification of adult human (Webster et al., 1988) , rat (Kaufman and Foster, 1988 ) and mouse (Blanco-Bose et al., 2001) satellite cells, this is the first Table 2 Muscle characteristic genes more expressed (>2 times) in embryonic or fetal myotubes Genes more expressed in fetal myotubes are depicted in grey. Reference for fiber type specificity: Bottinelli and Reggiani, 2000. time that this technique has been used for prenatal myogenesis to isolate murine embryonic and fetal myoblasts.
Differentiation/Proliferation characteristics of embryonic and fetal myoblasts in vitro
The data presented here demonstrate unequivocally that embryonic and fetal myoblasts are distinct populations of myogenic cells with different morphologies and fusion characteristics in vitro. These observations confirm previous reports on muscle colony forming cells and unpurified cell preparations isolated from chicken (Bonner and Hauschka, 1974) , rat (Pin and Merrifield, 1993) , mouse (Cusella-DeAngelis et al., 1992) and human (Hauschka, 1974) . Moreover the co-culture experiments presented here indicate that although murine embryonic and fetal myoblasts can fuse to each other, as previously reported for rat myoblasts (Pin and Merrifield, 1997) , they have a preference for omotypic fusion. This observation further supports the conclusion that embryonic and fetal myoblasts are distinct populations that behave differentially also when cultured together in the same dish.
Embryonic myoblasts differentiate more readily than their fetal counterparts in vitro. Since differentiation is normally associated with cell cycle exit (Lassar et al., 1994) it is not surprising that embryonic myoblasts also show reduced proliferation (as assayed by BrdU incorporation) and clono-genic ability. Notably, when evaluated by FACS analysis after Hoechst staining, freshly isolated populations of embryonic and fetal myoblasts were similar with regard to the fraction of proliferating cells (∼ 30% of the cells in S-G2-M; Fig. 1 ), suggesting that neither population is more differentiated than the other at the moment of isolation. Nevertheless, embryonic myoblasts have a greater propensity to differentiate compared to their fetal counterparts. From a teleological point of view, the increased tendency to differentiation shown by embryonic myoblasts may relate to the early formation of functional muscle fibers, needed by the embryo to move, and, for lower vertebrates, to feed and escape from predators. This strategy may have originally been adopted as a survival mechanism for embryos developing outside of a protected environment as in birds and mammals, and this characteristic may have been maintained during amniote evolution.
Differential responses of embryonic and fetal myoblasts to regulatory molecules
Vertebrate myogenesis is thought to occur in multiple phases involving different classes of progenitors, albeit direct lineage evidence for this notion is lacking. This enables the maintenance of a pool of precursors to cope with growth while at the same time, generating contracting, post-mitotic skeletal muscle fibers to allow early movements of the embryo. A possible mechanism to ensure that one class of myoblasts will differentiate in an environment that is permissive for the proliferation of other classes may be based on the inability of the former to respond to growth factors and/or to molecules that inhibit differentiation. A number of years ago, we proposed that TGFβ might influence the process of primary fiber formation in vivo, by inhibiting the differentiation of fetal, but not of embryonic myoblasts (Cusella-DeAngelis et al., 1994) . Data presented here demonstrate that embryonic and fetal myoblasts are indeed intrinsically different in their response to TGFβ supporting this hypothesis. The two populations of myoblasts also respond differently to BMP-4, further suggesting that multiple growth factors may cooperate to precisely regulate the timing of myoblast differentiation. There also appears to be a certain degree of redundancy among different BMP and different TGFβ isoforms, suggesting that this regulatory mechanism may be essential for correct muscle development. TPA also inhibits the differentiation of C2C12 and fetal, but not embryonic, myoblasts and although not normally present in the embryo, it may mimic the action of natural endogenous molecules that activate PKC. It was previously reported that satellite cells are insensitive to TPA (Cossu et al., 1988) . The sensitivity of C2C12 myoblasts to TPA is therefore surprising, as this line was originally isolated from regenerating adult (2-month-old) skeletal muscle and thus considered a model of satellite cells (Blau et al., 1983) . The molecular mechanisms that mediate the intracellular response of fetal myoblasts to TGFβ/BMP-4/TPA remain poorly understood, although the protein kinase C isoform PkCθ is involved (Zappelli et al., 1996) . When the expression of PkCθ in purified myoblast populations was accurately Fig. 10 . Evaluation of the expression of slow and fast fibers specific genes discloses a correlation between fetal myotubes and fast fibers and between embryonic myotubes and slow fibers. Transcript levels of 12 slow (1-12)-and 12 fast-specific (A-L) genes (see Table 2 and Supplementary Table 4 ) were evaluated by real-time PCR on purified populations after 3 days of differentiation in vitro. The level of expression of each gene in the embryonic (ordinate) and fetal (abscissa) population is represented by the ΔCt value, which is inversely and exponentially correlated to the amount of transcripts. Note that the majority of the slow-specific genes are expressed at higher level in embryonic population, whereas most of the fast-specific genes are more abundant in the fetal population. Bars represent ± SD between 4 technical replicates.
quantified by real-time PCR, the results showed particularly high expression in undifferentiated fetal myoblasts (when they are sensitive to the action of the TGFβ/BMP-4/TPA), consistent with previous reports of expression during secondary myogenesis (Zappelli et al., 1996) . In addition to PkCθ, microarray analysis revealed differential expression of other members of the TGFβ superfamily pathway (Decorin, Byglican, Cited1, Ltbps, Smad6 and Smad7) in the embryonic and fetal myoblasts. Moreover, we showed that several positive modulators of the Notch pathway resulted as upregulated in fetal myoblasts. By using the γ-secretase inhibitor L-685,458, we provide here evidence that in fetal myoblasts, functional Notch signaling is necessary for TGFβ, TPA and BMP-4 mediated inhibition of myogenic differentiation, in agreement with previous reports on C2C12 and satellite cells Dahlqvist et al., 2003) . Although mechanisms of Notch signaling not needing the release of the NICD fragment and acting in a CSL-independent way have been proposed (Bush et al., 2001) , the data reported here indicate that this TGFβ, TPA and BMP-4 induced block of differentiation requires the cleavage of Notch.
Pax3 and Pax7 in embryonic and fetal myoblasts
Pax3 and its paralogue Pax7 have been implicated in the specification of progenitor cells for the myogenic program. Recently, attempts have been made to elucidate both common and distinct features for these paralogues. It has been suggested that all cells of the myogenic lineage (embryonic and fetal myoblasts and satellite cells) are derived from a Pax3/7-positive population of myogenic progenitors resident in the dermomyotome (Kassar-Duchossoy et al., 2005; Relaix et al., 2005; Schienda et al., 2006) . These progenitors can differentiate into skeletal muscle fibers or remain as a reserve cell population within the growing muscle mass during peri-and postnatal stages. Pax3 and Pax7 are both expressed in embryonic myoblasts and satellite cells, although not necessarily in the same cell: in particular, Pax3 seems to be expressed only in a subset of adult satellite cells (Montarras et al., 2005) . Recent studies have shown that Pax3 and Pax7 have both distinct and overlapping functions in adult regenerative myogenesis (Kuang et al., 2006; Relaix et al., 2006) and during embryonic myogenesis (Relaix et al., 2004) . However, while the role of Pax genes in embryonic and postnatal myogenesis have been the subject of intense investigation, their function during fetal myogenesis remains unexplored. The data presented here show that essentially only Pax7 is expressed in fetal myoblasts. Although analysis at the single cell level was not carried out to exclude the possible expression of Pax3 in a small subset of fetal myoblasts, these data show that, as in satellite cells, Pax7 predominates during fetal myogenesis, in agreement with a recently published immunohistochemical analysis (Horst et al., 2006) . Interestingly, the satellite compartment and adult muscle regeneration are severely affected in the absence of Pax7, whereas fetal myogenesis appears unaffected (Seale et al., 2000) suggesting that compensatory mechanisms may act at the fetal stage, but not postnatally.
In addition to Pax3 itself, undifferentiated embryonic myoblasts also show relatively enhanced expression of several genes directly or indirectly linked to Pax3 expression, such as Meox1, Eya2 and Cadherin11. In contrast, expression levels of the Pax3 targets Six1 and c-Met are similar in embryonic and fetal myoblasts ( Fig. 7B and Supplementary microarray data) . c-Met is widely expressed by satellite cells, suggesting that activation of c-Met is Pax3-independent at the fetal and postnatal stage. Although Pax7 would be an obvious candidate, inefficient activation of c-Met during embryonic myogenesis occurs when Pax3 is replaced by Pax7 using a gene targeting strategy (Relaix et al., 2004) .
Other genes such as Meox2, Paraxis, FoxC1 and 2, Twist, Uncx4.1 and Ephrin B2 also show relatively high expression in embryonic compared with fetal myoblasts. Interestingly in Meox1/Meox2 double knockout embryos reduced expression of Pax3, Paraxis and Twist has been reported (Mankoo et al., 2003) and in FoxC1/FoxC2 double knockout mice there is a complete absence of somitic expression of Paraxis, Ephrin B2 and Uncx4.1 (Kume et al., 2001) . Taken together, these data strongly suggest the existence of a myogenic cascade that is active in the embryonic, but not in the fetal population of myoblasts.
Expression of a Hox code in embryonic myoblasts
Although morphologically very similar, somites differentiate into distinct mesodermal tissues, depending on their axial level. The identity of the somite is specified by a unique expression profile of Hox genes, generally referred as "HOX code" (Burke, 2000) . Classical transplantation experiments have shown that this segmental identity is able to influence the fate of sclerotomal (vertebrae and ribs) and non-myogenic dermomyotomal (back dermis and scapula) derivatives of the somite (Ehehalt et al., 2004; Jacob et al., 1975; Kieny et al., 1972; Mauger, 1972) . In contrast, it was generally accepted for many years that somitic myogenic precursors are completely naïve and do not possess positional information, depending exclusively on extrinsic cues to direct site-specific fate. This view was based on classical embryological experiments in the chick (Christ et al., 1977) , in which somites were heterotopically transplanted at the limb level such that the generation of graftderived appendicular muscles could be observed, but was recently challenged by Alvares et al. (2003) . Although several studies had already suggested that myogenic precursors in the somite could also have positional identity (Donoghue et al., 1992a; Donoghue et al., 1992b; Grieshammer et al., 1992; Murakami and Nakamura, 1991) , Alvares and coworkers clearly showed that the ability to generate either migratory (Lbx1 + ) or non-migratory (Lbx1 − ) muscle precursors is dependent upon intrinsic properties of the somite from which they were derived. These studies also showed that the limbs contain a potent signaling mechanism (i.e., FGFs) that can override the non-migratory program of flank somites and induce expression of the migration marker Lbx1. Further, the somitic predisposition towards a particular myogenic program (migratory or non-migratory) was shown to depend, directly or indirectly, on Hox genes. These findings show that results obtained by heterotopic grafting into the limb area (Christ et al., 1977) do not necessarily apply to other axial levels and conclusively demonstrate that the axial identity of the somites, conferred by HOX genes, can also determine the fate of skeletal muscle precursors. However, whether this positional information is intrinsically encoded in myoblasts or in neighboring cells within the same somite, remained unknown.
Data presented here demonstrate that embryonic myoblasts isolated from different positions along the antero-posterior axis are characterized by a pattern of Hox genes expression very similar to that documented for whole somites (Burke et al., 1995; Vogels et al., 1990) , clearly indicating that, in vivo, embryonic myoblasts express themselves a HOX code, and thus presumably posses direct positional information. These data are in agreement with the work of Alvares et al. (2003) and, moreover, show for the first time, that a HOX code exists in the embryonic myoblasts, which thus express HOX genes according to their cranio-caudal position. Further experiments in which myoblasts are purified by FACS from specific axial levels and then heterotypical transplanted would definitively show if the myoblast-specific Hox code reported here carries the positional information as previous experiments involving transplantation of the dermomyotomal compartment of the somite suggest (Fomenou et al., 2005) . In contrast, fetal myoblasts do not express Hox genes and are probably oriented by pre-existing primary fibers (Cossu and Biressi, 2005) .
"Pre-determination" of the fast and slow fiber phenotype Few genes are known to be differentially expressed between embryonic and fetal myotubes, including PkCθ and the musclespecific slow MyHC, β enolase and MCK (Barbieri et al., 1990; Ferrari et al., 1997; Zappelli et al., 1996; Zhang et al., 1998) . Using pure populations of embryonic and fetal myoblasts, it is now possible to analyze the expression of other, not necessarily muscle-specific, genes. Using real-time PCR, 40 genes were identified which are expressed more highly (> 2 times) in one or the other population (Table 2) . This analysis represents an important step towards the characterization of primary and secondary fibers. Notably, many of these differentially expressed transcripts correspond to genes for which differential expression has been reported between adult slow (Type I) and fast (Type II) fibers (Bottinelli and Reggiani, 2000) . It has already been proposed that the slow contracting Type I fibers and the fast contracting Type II fibers may be derived from prenatal primary and secondary fibers, respectively. This hypothesis is mainly based on the differential expression of slow and fast MyHC isoforms in embryonic and fetal myotubes, respectively (Kelly and Rubinstein, 1980) . However, it is not known whether primary and secondary fibers possess a genetic signature that can influence subsequent muscle fiber physiology in the adult. Although other influences like exercise, hormones, local factors and innervation also play an important role in modulating muscle fiber type phenotype (Wigmore and Evans, 2002) , data reported here strongly suggest the existence of a slow program in embryonic myoblast and of a fast program in fetal myoblasts. Likely, all the abovementioned mechanisms may cooperate in the establishment of the various subtypes of adult muscle fibers.
Concluding remarks
Thanks to a newly developed cell-sorting method it was possible to study murine embryonic and fetal myoblasts as purified populations. in vitro, the two classes of myoblast show intrinsically different fusion, proliferation and response to TGFβ and TPA, consistent with previous reports. Furthermore, a previously undescribed differential sensitivity to BMP-4 and accelerated rate of differentiation were observed. Microarray and real-time PCR analysis revealed a number of differentially expressed genes between the two populations, including several transcription factors and a number of contractile proteins, both before and after differentiation.
Collectively, these data clearly demonstrate that embryonic and fetal myoblasts correspond to intrinsically different myogenic lineages and represent a starting point for future studies to define the molecular basis of asynchronous skeletal muscle development.
